14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

BioShares Biotechnology Clinical Trials Fund Forecast

NASDAQ:BBC BUY SELL

$19.57 (0%)

Volume: 3.407k

Closed: May 16, 2022

Hollow Logo Score: -3.554

BioShares Biotechnology Clinical Trials Fund Forecast

BUY SELL NASDAQ:BBC
$19.57 (0%)

Volume: 3.407k

Closed: May 16, 2022

Score Hollow Logo -3.554

BBC Stock Trend

The fund lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the fund is expected to fall -24.86% during the next 3 months and, with a 90% probability hold a price between $13.05 and $19.36 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-18 $17.23 $21.42 $25.62
2022-05-19 $17.08 $21.28 $25.48
2022-05-20 $16.94 $21.14 $25.34
2022-05-23 $16.80 $21.00 $25.19
2022-05-24 $16.66 $20.85 $25.05
2022-05-25 $16.52 $20.71 $24.91
2022-05-26 $16.37 $20.57 $24.77
2022-05-27 $16.23 $20.43 $24.62
2022-05-31 $16.09 $20.29 $24.48
2022-06-01 $15.95 $20.14 $24.34
2022-06-02 $15.81 $20.00 $24.20
2022-06-03 $15.66 $19.86 $24.06
2022-06-06 $15.52 $19.72 $23.91
2022-06-07 $15.38 $19.58 $23.77
2022-06-08 $15.24 $19.43 $23.63
2022-06-09 $15.10 $19.29 $23.49
2022-06-10 $14.95 $19.15 $23.35
2022-06-13 $14.81 $19.01 $23.20
2022-06-14 $14.67 $18.87 $23.06
2022-06-15 $14.53 $18.72 $22.92
2022-06-16 $14.39 $18.58 $22.78
2022-06-17 $14.24 $18.44 $22.64
2022-06-21 $14.10 $18.30 $22.49
2022-06-22 $13.96 $18.16 $22.35
2022-06-23 $13.82 $18.01 $22.21
2022-06-24 $13.68 $17.87 $22.07
2022-06-27 $13.53 $17.73 $21.93
2022-06-28 $13.39 $17.59 $21.78
2022-06-29 $13.25 $17.45 $21.64
2022-06-30 $13.11 $17.30 $21.50

About BioShares Biotechnology Clinical Trials Fund

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT